A multicenter, open-label, long-term study of three-year infliximab administration in Japanese patients with ankylosing spondylitis

Kobayashi Shigeto; Yoshinari Toru

首页> 外文期刊>Modern rheumatology >A multicenter, open-label, long-term study of three-year infliximab administration in Japanese patients with ankylosing spondylitis

【24h】

A multicenter, open-label, long-term study of three-year infliximab administration in Japanese patients with ankylosing spondylitis

机译：三年脊柱脊柱炎患者三年英夫利昔单抗管理的多中心，开放标签，长期研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective: To investigate the efficacy, safety, and pharmacokinetics of infliximab (IFX) in Japanese patients with active ankylosing spondylitis (AS).

机译：目的：探讨日本患者的嗜绒突腰巴（IFX）的活性强直性脊柱炎（AS）的疗效，安全性和药代动力学（AS）。

著录项

来源
《Modern rheumatology》 |2017年第1期|共8页
作者
Kobayashi Shigeto; Yoshinari Toru;
展开▼
作者单位

Juntendo Univ Koshigaya Hosp Dept Internal Med Div Rheumatol 560 Fukuroyama Koshigaya Saitama;

Mitsubishi Tanabe Pharma Corp Sohyaku Innovat Res Div Tokyo Japan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类免疫性疾病;
关键词
Infliximab; Ankylosing spondylitis; Anti-TNF alpha monoclonal antibody; Japan; Clinical trial;

机译：英夫利昔单抗;强直性脊柱炎;抗TNFα单克隆抗体;日本;临床试验;

相似文献

外文文献
中文文献
专利

1. A multicenter, open-label, long-term study of three-year infliximab administration in Japanese patients with ankylosing spondylitis [J] . Kobayashi Shigeto, Yoshinari Toru Modern rheumatology . 2017,第1期

机译：三年脊柱脊柱炎患者三年英夫利昔单抗管理的多中心，开放标签，长期研究
2. A multicenter, open-label, efficacy, pharmacokinetic, and safety study of adalimumab in Japanese patients with ankylosing spondylitis [J] . KobayashiS., HarigaiM., MozaffarianN., Modern rheumatology . 2012,第4期

机译：阿达木单抗在日本强直性脊柱炎患者中的多中心，开放标签，疗效，药代动力学和安全性研究
3. Multicenter open-label study with infliximab in active ankylosing spondylitis over 28 weeks in daily practice. [J] . Haibel H, Song IH, Rudwaleit M, Clinical and experimental rheumatology . 2008,第2期

机译：在日常实践中，英夫利昔单抗治疗活动性强直性脊柱炎的多中心开放研究超过28周。
4. VISCOELASTIC PROPERTIES OF THE L3-L4 MYOFASCIAL TISSUE IN ANKYLOSING SPONDYLITIS PATIENTS [C] . Allison White, Hannah Abbott, Alfonse Masi, ASME International Mechanical Engineering Congress and Exposition . 2019

机译：L3-L4肌动虫组织在强直性脊柱炎患者中的粘弹性特性
5. Efficacy and safety of novel collagen conduits filled with collagen filaments to treat patients with peripheral nerve injury: A multicenter, controlled, open-label clinical trial [D] . Saeki Masaomi, 佐伯将臣 2019

机译：充满胶原细丝的新型胶原蛋白导管治疗周围神经损伤患者的疗效和安全性：一项多中心，对照，开放标签的临床试验
6. A multicenter open-label efficacy pharmacokinetic and safety study of adalimumab in Japanese patients with ankylosing spondylitis [O] . Shigeto Kobayashi, Masayoshi Harigai, Neelufar Mozaffarian, -1

机译：阿达木单抗在日本强直性脊柱炎患者中的多中心开放标签疗效药代动力学和安全性研究
7. A multicenter, open-label, efficacy, pharmacokinetic, and safety study of adalimumab in Japanese patients with ankylosing spondylitis [O] . Shigeto Kobayashi, Masayoshi Harigai, Neelufar Mozaffarian, 2011

机译：阿达木单抗在日本强直性脊柱炎患者中的多中心，开放标签，疗效，药代动力学和安全性研究

A multicenter, open-label, long-term study of three-year infliximab administration in Japanese patients with ankylosing spondylitis

摘要

著录项

相似文献

相关主题

期刊订阅